MDQAS has provided Authorized Representative Services continuously since 1996 to a wide range of medical device manufacturers across the world.
On July 1st 2015, Medical Device & QA Services Ltd was formally acquired by Advena Ltd. The high level of service provided by MDQAS will be continued via the Advena team for new and existing clients.
All MDQAS European Authorised Representative (AR) contracts (mandates) and fees remain unchanged as well as the MDQAS contact address legally required on product packaging and labelling or on any associated Notified Body EU certificate.
New invoices for the annual renewal of MDQAS contracts will be issued by the Advena Ltd accounts department and will clearly state that although the sums invoiced relate to existing client contracts with MDQAS they are to be paid to Advena Ltd.
The only substantial change is that communications in future will be via John Adcock (firstname.lastname@example.org) or a member of his team (MDQAS@advenamedical.com) as the new owners of MDQAS.
From July 1st 2015, European Authorised Representative contracts for new clients will be directly with Advena Ltd.
Advena and MDQAS have worked together for many years as active members of the European Association of Authorised Representatives, sharing the same ethos to lower the cost and complexity of compliance for our clients, with a friendly professional approach.
Advena’s EU Authorized Representative Service goes beyond the obligations of European Medical Device Directives and associated EU guidelines, to provide professional advice and vital regulatory news updates.